Litcius/Paper detail

Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial

Dian Zhou, Qian Sun, Jieyun Xia, Weiying Gu, Jun Qian, Wanchuan Zhuang, Zhiling Yan, Hai Cheng, Wei Chen, Feng Zhu, Kunming Qi, Depeng Li, Wei Sang, Lili Zhu, Sha Ma, Hujun Li, Huan-Xin Zhang, Tingting Qiu, Dongmei Yan, Yanlei Zhang, Shuixiu Peng, Alex H. Chang, Kailin Xu, Zhenyu Li

2024The Lancet Haematology50 citationsDOI

Topics & Concepts

MedicineChimeric antigen receptorMultiple myelomaRefractory (planetary science)AntigenCancer researchOncologyInternal medicineImmunologyImmunotherapyCancerAstrobiologyPhysicsCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses